Population-based pattern of medication use and prevalence of polypharmacy among patients with cardiovascular diseases: results of the Pars cohort study from Iran

被引：0
作者：
Pooran Mohsenzadeh
Ali Ardekani
Hossein Poustchi
Zahra Mohammadi
Seyed Reza Abdipour Mehrian
Hamed Bazrafshan Drissi
Zahra Rahimian
Erfan Taherifard
Ali Nabavizadeh
Alireza kamalipour
Bita Mesgarpour
Fatemeh Malekzadeh
Hossein Molavi Vardanjani
机构：
[1] Shiraz University of Medical Sciences,MPH Department, School of Medicine
[2] Shiraz University of Medical Sciences,Health Policy Research Center, Institute of Health
[3] Tehran University of Medical Sciences,Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute
[4] Shiraz University of Medical Sciences,Department of Cardiology, School of Medicine
[5] Shiraz University of Medical Sciences,Student Research Committee
[6] University of California,Department of Ophthalmology, Hamilton Glaucoma Center, Shiley Eye Institute
[7] National Institute for Medical Research and Development (NIMAD),Vice Chancellery for Research and Technology
[8] Tehran University of Medical Sciences,Digestive Diseases Research Center, Digestive Diseases Research Institute, Shariati Hospital
[9] Shiraz University of Medical Sciences,MPH Department, School of Medicine, Research Center for Traditional Medicine and History of Medicine
来源：
BMC Cardiovascular Disorders | / 22卷
关键词：
Polypharmacy; Medication adherence; Cardiovascular diseases; Prevalence;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 182 条
  • [1] Gyasi RM(2019)Aging and the rising burden of noncommunicable diseases in sub-Saharan Africa and other low- and middle-income countries: a call for holistic action Gerontologist 60 806-811
  • [2] Phillips DR(2019)The global burden of cardiovascular diseases and risk factors: 2020 and beyond J Am Coll Cardiol 74 2529-2532
  • [3] Mensah GA(2018)Polypill: an affordable strategy for cardiovascular disease prevention in low–medium-income countries Ther Adv Cardiovasc Dis 12 169-174
  • [4] Roth GA(2014)Comorbidities and polypharmacy Heart Fail Clin 10 367-372
  • [5] Fuster V(2019)Polypharmacy: a healthcare conundrum with a pharmacogenetic solution Crit Rev Clin Lab Sci 8 81-5
  • [6] López-Jaramillo P(2005)Inappropriate prescribing practices: the challenge and opportunity for patient safety Healthc Q 31 421-298
  • [7] González-Gómez S(2016)Prevalence and covariates of polypharmacy in elderly patients on discharge from a tertiary care hospital in Oman Oman Med J 2 53-1194
  • [8] Zarate-Bernal D(2012)Study on polypharmacy in patients with cardiovascular diseases J Appl Pharm Sci 15 289-1196
  • [9] Serrano A(2020)Prevalence and determinants of polypharmacy in cardiovascular patients attending outpatient clinic in Ethiopia University Hospital PLoS ONE 16 2042098620933741-319
  • [10] Atuesta L(2021)Polypharmacy prevalence in older adults seen in United States physician offices from 2009 to 2016 PLoS ONE 10 1187-392
12345678910